| Literature DB >> 33160375 |
Ijeoma Nkem Okedo-Alex1,2, Ifeyinwa Chizoba Akamike1,2, Chihurumnanya Nwachi Alo2, Adaoha Pearl Agu1,2, Chinyere Benedicta Nzeh1, Chinwendu Daniel Ndukwe1, Odii Ogonna Okoro1, Dejene Derseh Abateneh3, Chigozie Jesse Uneke1.
Abstract
BACKGROUND: Innovative community strategies to increase intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) coverage is advocated particularly in rural areas, where health infrastructure is weakest and malaria transmission highest. This study involved proof-of-concept implementation research to determine satisfaction with and effectiveness of community-directed distribution of IPTp-SP on uptake among pregnant women in Ebonyi State, Nigeria.Entities:
Keywords: Community-directed distribution; Effectiveness; Malaria; Nigeria; Pregnancy; Satisfaction; Sulfadoxine-pyrimethamine
Mesh:
Substances:
Year: 2020 PMID: 33160375 PMCID: PMC7648974 DOI: 10.1186/s12936-020-03468-2
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Monthly socio-demographic, antenatal and malaria-related characteristics of the respondents during the study intervention period.
Data source: Client visitation and monthly summary forms
| Variable | Month 1 n = 143 (%) | Month 2 n = 158 (%) | Month 3 n = 153 (%) | Month 4 n = 230 (%) | Month 5 n = 155 (%) |
|---|---|---|---|---|---|
| Mean age ± SD | 25.8 ± 5.0 | ||||
| At least one ANC visit | 111 (77.6) | 147 (93.0) | 127 (83.0) | 177 (77.0) | 136 (87.7) |
| Mean number of ANC attended | 2.9 ± 1.4 (n = 111) | 3.0 ± 1.8 (n = 147) | 3.1 ± 1.7 (n = 127) | 3.2 ± 1.5 (n = 177) | 3.0 ± 2.1 (n = 155) |
| Ever received IPTp | 80 (55.9) | 105 (66.5) | 130 (85.0) | 164 (71.3) | 133 (85.8) |
| Source of IPTp | |||||
| PHC | 55 (38.5) | 40 (25.3) | 18 (11.8) | 31 (13.5) | 12 (7.7) |
| CDD | 0 (0.0) | 53 (33.5) | 108 (70.6) | 127 (55.2) | 121 (78.1) |
| Patent medicine vendor | 24 (16.8) | 12 (7.6) | 4 (2.6) | 6 (2.6) | 0 (0.0) |
| Others | 1 (0.7) | 1 (0.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| ITN Ownership | 121 (84.6) | 130 (82.3) | 130 (85.0) | 195 (84.8) | 143 (92.3) |
| Slept under ITN the night before survey | 118 (82.5) | 128 (81.0) | 129 (84.3) | 194 (84.3) | 142 (91.6) |
| Had a fever in this pregnancy | 62 (43.4) | 44 (27.8) | 27 (17.6) | 39 (17.0) | 33 (21.3) |
| Treated for malaria in this pregnancy | 56 (39.2) | 73 (46.2) | 35 (22.9) | 60 (26.1) | 31 (20.0) |
IPTp (IPT1-1PT6) uptake by month during the study intervention period.
Data source: Monthly summary forms
| IPT doses | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Total |
|---|---|---|---|---|---|---|
| IPT 1 | 65 | 53 | 23 | 66 | 22 | 229 |
| IPT 2 | 34 | 48 | 40 | 59 | 51 | 232 |
| IPT 3 | 28 | 43 | 61 | 43 | 42 | 217 |
| IPT 4 | 15 | 14 | 24 | 49 | 19 | 121 |
| IPT 5 | 1 | 0 | 5 | 11 | 17 | 34 |
| IPT 6 | 0 | 0 | 0 | 2 | 4 | 6 |
| Total | 143 | 158 | 153 | 230 | 155 |
Doses of IPTp-SP taken during pregnancy at baseline and in the fourth month of the intervention.
Data source: Baseline survey and client visitation and summary forms in the fourth month post-initiation of community-directed distribution of IPTp
| IPT Dose | Baseline | Month 4 of the intervention | χ2 (P value) |
|---|---|---|---|
| n = 242 | n = 303 | ||
| n (%) | n (%) | ||
| IPT 1 | 56 (23.1) | 229 (75.6) | 148.3 (< 0.001)a |
| IPT 2 | 44 (18.2) | 232 (76.6) | 183.5 (< 0.001)a |
| IPT 3 | 76 (31.4) | 217 (71.6) | 87.4 (< 0.001)a |
| IPT 4 or more | 31 (12.8) | 161 (53.1) | 95.9 (< 0.001)a |
aStatistically significant
Access to antenatal care and malaria-related characteristics at baseline and in the fourth month of the intervention.
Data source: Baseline survey and client visitation and summary forms in the fourth month post-initiation of community-directed distribution of IPTp
| Variable | Baseline | 4th month of the intervention | χ2 (P-value) |
|---|---|---|---|
| n= 242 | n = 230 | ||
| n (%) | n (%) | ||
| At least one ANC visit | 228 (94.2) | 177 (77.0) | 28.8 (< 0.001)a |
| ITN ownership | 192 (79.3) | 195 (84.8) | 2.36 (0.124) |
| Slept under ITN a night before the interview | 151 (62.4) | 194 (84.3) | 28.9 (< 0.001)a |
| Fever while pregnant | 157 (64.9) | 39 (17.0) | 111.3 (< 0.001)a |
aStatistically significant
Satisfaction with the community-directed distribution of IPTp-SP and IPTp administration preferences among women who received IPTp through CDDs in the community (n = 377).
Data source: Post-implementation survey at end of the fifth month among women who received IPTp through CDDs in the community
| Variable | Frequency | Percent (%) |
|---|---|---|
| Rating of CDD services | ||
| Excellent | 215 | 57.0 |
| Good | 138 | 36.6 |
| Average | 24 | 6.4 |
| Poor | 0 | 0.0 |
| Very poor | 0 | 0.0 |
| Satisfaction with CDI-IPTp project | ||
| Very satisfied | 211 | 56.0 |
| Satisfied | 159 | 42.2 |
| Neutral | 0 | 0.0 |
| Unsatisfied | 4 | 1.1 |
| Very dissatisfied | 3 | 0.8 |
| IPTp administration strategy preference | ||
| Facility-based | 29 | 7.7 |
| Community-based | 348 | 92.3 |
Fig. 1The trend of ITN use a night before the survey and occurrence of fever during pregnancy